You are currently browsing the Osteoarthritis Blog blog archives for the day Tuesday, January 18th, 2011.

Calendar

January 2011
M T W T F S S
« Dec   Feb »
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Archive for January 18th, 2011

Celebrex

Celebrex

116,00 patients takings non steroidal anti inflammatory drugs (NSAIDs) were studied by The British Journal of Medicine.  This recent publication states that taking certain medications, like celecoxib, will increase the risk of cardiovascular events in patients, especially as the dosage increases.  Celecoxib is sold as Celebrex by the pharmaceutical giant Pfizer.

Pfizer is the world’s largest drug maker.  In 2004 Pfizer spent $117 Million in advertising Celebrex.  In 2005 the FDA forced a moratorium on Pfizer’s advertising efforts of Celebrex because of the cardiovascular risks.  Sales of Celebrex plummeted by $1.7 BILLION.  Four months later the advertising ban was lifted.

Now Pfizer must print that “Celebrex may increase the chance of a heart attack or stroke that can lead to death” on every box sold.   Consumer groups have launched campaigns in magazines that Pfizer should be forced to stop selling Celebrex, not encouraging people to use it.

So why have you never heard of treating knee osteoarthritis with a knee brace?  Because the companies that manufacture them are small.  They cannot compete with big pharma.  Pfizer spent $117 million on advertising one single drug in 2004.  The companies that manufacture braces to treat osteoarthritis measure their advertising budgets in the tens of thousands.  Billions and billions of dollars are spent annually to treat osteoarthritis.  Half of one percent of that money is spent on bracing.

Talk to your doctor, do your homework, and try conservative treatments for your knee OA.  There are much safer options than drugs.  NSAIDs kill.  Knee braces do not.